Showing results (301-310 of 445) with videos related to
Sort By:
Pageof 45
Journal of the Neurological Sciences|December 12, 1997
Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention studyR Schmidt, F Fazekas, M Hayn, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancerZ A Wainberg, P C Enzinger, S Qin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Identification of potentially avoidable hospitalizations in patients with GI cancerGabriel A Brooks, Thomas A Abrams, Jeffrey A Meyerhardt, et al.Virchows Archiv : an International Journal of Pathology|March 21, 2007
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinomaShuji Ogino, Jeffrey A Meyerhardt, Takako Kawasaki, et al.Gynecologic Oncology|July 2, 2024
Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysisJaclyn A Wall, Rachel A Pozzar, Andrea C Enzinger, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Comparison of CT, MR, and PET in Alzheimer's dementia and normal agingF Fazekas, A Alavi, J B Chawluk, et al.Clinical Colorectal Cancer|October 10, 2006
Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancerBrian M Wolpin, Jeffrey W Clark, Jeffrey A Meyerhardt, et al.Cancer Investigation|October 10, 2003
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancerDavid P Ryan, Jeffrey W Clark, Matthew H Kulke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2009
Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904Matthew H Kulke, Margaret A Tempero, Donna Niedzwiecki, et al.European Journal of Neurology|July 16, 2010
Thrombolytic therapy for acute stroke in Austria: data from the Safe Implementation of Thrombolysis in Stroke (SITS) registerR Topakian, M Brainin, R Eckhardt, et al.Pageof 45